EADV 2026: Lebrikizumab improved hand and foot clearance, itch, and pain at 16 weeks versus placebo in a phase 3b atopic dermatitis trial.
News|Articles|September 2, 2010
What Are These Scaly Plaques?
These scaly plaques on the scalp of a 32-year-old man have failed to respond to a topical antifungal. The patient has a 3-year history of pulmonary sarcoidosis.
Advertisement
These scaly plaques on the scalp of a 32-year-old man have failed to respond to a topical antifungal. The patient has a 3-year history of pulmonary sarcoidosis.
Would you switch to a different antifungal agent-or is something else going on here?
Answer: Cutaneous manifestation of sarcoidosis
For more information about this case,
(Case and photograph courtesy of Drs Frederick Wenzel and Eva Simmons-O’Brien.)
Advertisement
Related to this article
The FDA has approved baricitinib for adolescents aged 12 and older with severe alopecia areata, marking the first systemic oral therapy cleared for this population.
Takeda’s oral TYK2 inhibitor showed rapid skin clearance in phase 3 psoriasis trials as FDA fast-tracks review; decision expected early 2027.
Advertisement
Advertisement
Trending on Patient Care Online
1
Switch to Oral Semaglutide Linked to 4.1% Weight Loss at 3 Months in New Study
2
Atrial Fibrillation Stroke Prevention: Expert Guidance for Primary Care Physicians
3
Fezolinetant Linked to 2.6 Fewer Nighttime Awakenings in Women With Menopausal VMS
4
Long-Term and Real-World Safety Data on Antipsychotic Agitation Therapy
5